The Pennant Group (NASDAQ:PNTG) Announces Earnings Results

The Pennant Group (NASDAQ:PNTG) announced its quarterly earnings results on Wednesday. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.36 by ($0.01), FiscalAI reports. The firm had revenue of $302.25 million during the quarter, compared to the consensus estimate of $299.34 million. The Pennant Group had a net margin of 2.93% and a return on equity of 10.33%.

The Pennant Group Price Performance

PNTG traded up $2.85 during trading on Wednesday, hitting $44.04. The company’s stock had a trading volume of 370,000 shares, compared to its average volume of 295,684. The firm’s 50 day moving average price is $40.15 and its two-hundred day moving average price is $35.61. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.48. The Pennant Group has a 12 month low of $22.25 and a 12 month high of $44.24. The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of 48.93, a price-to-earnings-growth ratio of 2.64 and a beta of 1.33.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on PNTG. Royal Bank Of Canada raised their target price on shares of The Pennant Group from $42.00 to $44.00 and gave the company an “outperform” rating in a research note on Thursday, August 20th. Weiss Ratings upgraded The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, August 19th. Truist Financial boosted their target price on shares of The Pennant Group from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Finally, Wells Fargo & Company increased their price target on shares of The Pennant Group from $45.00 to $46.00 and gave the company an “overweight” rating in a report on Tuesday, August 11th. Five investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $46.00.

About The Pennant Group

The Pennant Group, Inc is a healthcare services company that operates home health, hospice and senior living businesses in the United States. Through its affiliated agencies and communities, the company provides skilled nursing, physical, occupational and speech therapy, personal care, hospice and palliative services, assisted living, and other support for older adults and individuals recovering from illness or injury.

Pennant’s home health and hospice operations serve patients in their homes and other residential settings, while its senior living segment operates communities that provide assisted living and related services.